Foster, Nathan R <br/><br/>
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Jul 2015 
 - 1099-106 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0000000000000548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Clinical Trials as Topic--methods<br/>Clinical Trials, Phase II as Topic--methods<br/>Clinical Trials, Phase III as Topic--methods<br/>Disease-Free Survival<br/>Endpoint Determination<br/>Female<br/>Humans<br/>Lung Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Randomized Controlled Trials as Topic--methods<br/>Small Cell Lung Carcinoma--mortality<br/>Survival Analysis<br/>Young Adult